Department of Defense
The Department of Defense has announced the following new funding opportunities:
Department of the Army - USAMRAA
DoD Lung Cancer Career Development Award
DoD Lung Cancer Exploration Award
DoD Lung Cancer Idea Development Award
Clinical & Translational Science Collaborative – Career Development Training Opportunity
The Clinical & Translational Science Collaborative (CTSC) KL2 a post-doctoral training program with an emphasis on multidisciplinary clinical and translational research, offers an innovative career development opportunity for qualified candidates.
The CTSC KL2 is designed to train the nation’s future leaders in clinical and translational research, and is part of the NIH Roadmap aimed at “re-engineering the clinical research enterprise.” The CTSC KL2 has just welcomed this year’s cohort of scholars, who were selected from a highly competitive pool of applicants:
- Mohamed Abazeed, MD, PhD (Radiation Oncology; Translational Hematology & Oncology, CCF)
- Stefanie Avril, MD (Pathology, CWRU)
- Nicholas Schiltz, PhD (Epidemiology & Biostatistics, CWRU)
- Jennifer Sweet, MD (Neurosurgery, University Hospitals Case Medical Center)
CTSC KL2 is now seeking applications for next year’s cohort.
Qualified candidates must:
- Hold an MD, PhD, DDS, PharmD, PsyD, or equivalent degree
- Demonstrate a keen interest in clinical research
- Have an appointment in one of the CTSC partner institutions on or before July 1, 2016
- Be a U.S. citizen or have permanent resident status
Each scholar will embark on a 4-year program of intensive training in multidisciplinary team-based, patient-oriented clinical research, combining an innovative curriculum with mentored research experiences.
Applications will be accepted between 7/1/15 and 10/12/15.
For more information, contact Beth Spyke, MPA, at firstname.lastname@example.org / 216.444.2702 or Raed Dweik, MD, at email@example.com / 216-445-5763. You may also request to schedule an information session.
For additional information, visit the CTSC webpage.
National Multiple Sclerosis Society – Health Care Delivery and Policy Research Contracts
The National Multiple Sclerosis Society announces the following funding opportunities:
• What are the factors related to cost-escalation of MS DMT's and how does the cost of DMT's, particularly out of pocket costs, relate to access to DMT's, payer's policies concerning coverage, initiation of and adherence to therapy, and the ways in which people with MS view the value of treatment? The Society would like to fund this priority in two phases with the cost component on a fast-tracked basis and the value component as a longer-term component.
• What is the extent to which people with MS utilize complementary and alternative medicine? To what extent is this utilization part of an integrative medicine approach that combines mainstream medicine and CAM? What are the policies followed by payers for coverage of CAM independently and as part of integrative medicine?
• What are the barriers preventing access to rehabilitation services, particularly maintenance services among people with MS and what are some of the potential solutions to these barriers?
Letter of Intent Deadline: October 7, 2015
For more information visit the National MS Society webpage.
Registration Now Open: OHRP Research Community Forum
Innovations in Research: Collaborations & Transformations
Wednesday, September 16, 2015
8:00 am - 6:00 pm
Global Center for Health Innovation
Registration Fee: $125
The Office for Human Research Protections (OHRP) of the United States Department of Health & Human Services (HHS), along with University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University (CWRU), will be hosting an all-day Research Community Forum at the Global Center for Health Innovation in Cleveland, Ohio.
This conference will feature a unique program focused on research innovation, with representatives from OHRP as well as experts from industry and academic institutions. The content of the program will benefit all members of the research enterprise.
Researchers, research coordinators, Institutional Review Board (IRB) members and staff, institutional officials, other public health service agencies, emerging bioscience companies entering human research and anyone with an interest in research involving human subjects should consider attending this informative and interesting one-day conference.
For additional information and registration, see http://events.r20.constantcontact.com/register/event?oeidk=a07eb321k9pd223cc69&llr=hr5hpguab.
National Institutes of Health – Transformative Research Award Program
The Transformative Research Award, run under the NIH Common Fund, was established to support exceptionally innovative, high-risk, and/or unconventional research projects that have the potential to create or overturn fundamental paradigms or otherwise have unusually broad impact. Such projects, due to their inherent risk, may be more difficult to support using a standard NIH R01 grant, but due to their potential impact, may merit pursuing. Little or no preliminary data are expected, but projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.
Letter of Intent Deadline: September 9, 2015
Application Deadline: October 9, 2015
For more information visit the NIH webpage.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be